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Reduced systemic insulin signaling promotes endothelial dysfunction and diminished endogenous
vascular repair. We investigated whether restoration of endothelial insulin receptor expression
could rescue this phenotype. Insulin receptor knockout (IRKO) mice were crossed with mice
expressing a human insulin receptor endothelial cell–specific overexpression (hIRECO) to produce
IRKO-hIRECO progeny. No metabolic differences were noted between IRKO and IRKO-hIRECOmice
in glucose and insulin tolerance tests. In contrast with control IRKO littermates, IRKO-hIRECO mice
exhibited normal blood pressure and aortic vasodilatation in response to acetylcholine, comparable
to parameters noted in wild type littermates. These phenotypic changes were associated with
increased basal- and insulin-stimulated nitric oxide production. IRKO-hIRECO mice also demon-
strated normalized endothelial repair after denuding arterial injury, which was associated with
rescued endothelial cell migration in vitro but not with changes in circulating progenitor pop-
ulations or culture-derived myeloid angiogenic cells. These data show that restoration of endo-
thelial insulin receptor expression alone is sufficient to prevent the vascular dysfunction caused by
systemically reduced insulin signaling. (Endocrinology 159: 2917–2925, 2018)
Many cellular lineages are insulin sensitive, and soinsulin signaling is likely to play a critical physi-
ological role beyond regulating systemic glucose homeo-
stasis. Mice with global or endothelium-restricted reduction
in insulin signaling exhibit vascular endothelial dysfunction,
hypertension, accelerated atherosclerosis, and reduced vas-
cular repair (1–6). We have recently shown that mice with
increased endothelial insulin signaling [due to human insulin
receptor endothelial cell–specific overexpression (hIRECO)]
also have endothelial dysfunction and accelerated
atherosclerosis, further supporting the need for normal
endothelial insulin signaling in vascular homeostasis (7).
However, it remains unclear whether normalization of
endothelial insulin receptor expression in mice with
systemically reduced insulin receptor expression is sufficient
to rescue their vascular function. This would more
convincingly prove the role of endothelial insulin receptors,
because gene knockout studies can report phenotypes due
to off-target “compensatory” gene expression rather than
loss of the target gene (8). In other words, robust proof of a
gene’s function requires phenotypic rescue when gene ex-
pression is restored in a knockoutmodel; however, this level
of proof is rarely reported by in vivo studies.
We have previously demonstrated that mice with
global haploinsufficiency of the insulin receptor [insulin
receptor knockout (IRKO) mice] are normoglycemic yet
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have endothelial dysfunction and impaired endothelial
repair (3, 4). To establish whether diminished endothelial
insulin receptor expression per se causes this phenotype,
we crossed IRKO mice with hIRECO mice to generate
IRKO-hIRECO progeny and contrasted their vascular
function with that of IRKO mice; data describing wild-
type (WT) littermates are also provided for reference (7).
Materials and Methods
Breeding and maintenance of mice
IRKO-hIRECO mice were derived by breeding male IRKO
with female hIRECO mice (3, 7), resulting in either WT, IRKO,
hIRECO, or IRKO-hIRECO progeny; hIRECO littermates were
not used in this study. Briefly, IRKO mice have global hap-
loinsufficiency of the insulin receptor, whereas hIRECO mice
express a human insulin receptor transgene under transcriptional
control of the Tie2 promoter-enhancer. The absence of hIRECO
transgene expression in myeloid cells has been confirmed in our
previous work (7). Mice were housed in a conventional animal
facility with a 12-hour light/dark cycle and received ad libitum
access to a standard laboratory diet unless fasted for metabolic
testing. Male mice aged 3 to 4 months were used, except for
pulmonary endothelial cell isolation,which used 4- to 6-week-old
male mice. Genotyping was performed with PCR and genomic
DNA derived from ear notches (3, 7). Primer sequences are listed
in Table 1. All procedures were performed according to accepted
standards of humane animal care, approved by the ethical review
committee of the University of Leeds, and conducted under
license from the United Kingdom Home Office.
Metabolic assessment
Serum insulin ELISA (Crystal Chem, Zaandam,Netherlands),
glucose tolerance tests and insulin tolerance tests were performed
as previously described in 3- to 4-month-old mice (9).
Blood pressure assessment
Blood pressure was measured by tail volume-pressure re-
cording in conscious 3- to 4-month-old mice as previously
described (3). In brief, tail cuff plethysmography (Coda non-
invasive tail blood pressure cuff; Kent Scientific, Torrington,
CT) was performed in a restraining chamber heated to 32°C,
after mice had undergone two acclimatization sessions on
preceding days. During the experimental session, data from the
first 10 acclimatization cycles were discarded before three cycles
of six blood pressure measurements were collected, the mean of
which was used to provide a single data point per mouse.
Because our published work has reported only elevated systolic
blood pressure in IRKO mice, we measured only systolic blood
pressure in these experiments.
Vascular function studies
Vasomotor function was assessed in aortic rings of 3- to
4-month-oldmice, as previously described (9). Ringsweremounted
in an organ bath containing Krebs-Henseleit buffer (composition,
in mmol/L: NaCl 119, KCl 4.7, KH2PO4 1.18, NaHCO3 25,
MgSO4 1.19, CaCl2 2.5, and glucose 11.0) gassed with 95%
O2/5%CO2. Rings were equilibrated at a resting tension of 3 g for
45 minutes before the experiments. A cumulative dose-response to
the constrictor phenylephrine (PE) (1 nmol/L to 100 mmol/L) was
first performed. Relaxation responses to cumulative addition of
acetylcholine (1 nmol/L to 100 mmol/L) and sodium nitroprusside
(SNP) (0.01 nmol/L to 100 mmol/L) were then carried out in rings
preconstricted with 300 nmol/L PE. Relaxation responses are
expressed as percentage decrement in preconstricted tension.
Bioavailable nitric oxide (NO) in aortic segments subjected to
isometric tension was measured by recording the change in
PE-induced tension elicited by the NO synthase inhibitor
L-NMMA (0.1 mmol/L) (7).
NO synthase activity
Endothelial nitric oxide synthase (eNOS) activity was de-
termined by conversion of [14C]L-arginine to [14C]L-citrulline, as
we previously described (9). Aortic rings (5 mm in length) were
incubated at 37°C for 20 minutes in HEPES buffer (pH 7.4):
10 mmol/L HEPES, 145 mmol/L NaCl, 5 mmol/L KCl, 1 mmol/L
MgSO4, 10 mmol/L glucose, and 1.5 mmol/L CaCl2, containing
0.25% BSA. We then added 0.5 mCi/mL [14C]L-arginine for
5 minutes, and tissues were stimulated with insulin (100 nmol/L)
for 30 minutes before the reaction was stopped with cold PBS,
containing 5mmol/L L-arginine and 4mmol/L EDTA, after which
tissue was denatured in 95% ethanol. After evaporation, the
soluble cellular components were dissolved in 20mmol/L HEPES-
Na+ (pH 5.5) and applied to a well-equilibrated DOWEX (Na+
form; SigmaAldrich, St Louis,MO) column. The [14C]L-citrulline
content of the eluatewas quantified by liquid scintillation counting
Table 1. Details of All Quantitative PCR Primers
Primer Sequence or Manufacturer Code
Genotyping
IRKO (forward 1) TTAAGGGCCAGCTCATTCCTCC
IRKO (forward 2) AGCTGTGCACTTCCCTGCTCAC
IRKO (reverse) TCTTTGCCTGTGCTCCACTCTCA
hIRECO (forward) ACGTCAGTAGTCATAGGAACTG-CGGTCG
hIRECO (reverse) TGCCTTGATTCACCAGATGCTG-AGG
Quantitative RT-PCR
Human insulin receptor (forward) TGCCACCAACCCCTCTGT
Human insulin receptor (reverse) CGGAGGGTGGTTTCCACTT
Murine b-actin (forward), for normalization of human insulin receptor CGTGAAAAGATGACCCAGATCA
Murine b-actin (reverse), for normalization of human insulin receptor TGGTACGACCAGAGGCATACAG
Murine insulin receptor TaqMan probe (Thermo Fisher, Waltham, MA)
Mm_01211875_m1
Murine b-actin, for normalization of murine insulin receptor TaqMan probe (Thermo Fisher) Mm_00607939
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and normalized against the weight of tissue used or total
cellular protein.
Vascular injury
Experiments were conducted in 3- to 4-month-old mice as pre-
viously described (4). Briefly, femoral arterial injury was produced
with an angioplasty guidewire and re-endothelialization assessed
4 days later by infusion of Evans blue dye. Data are presented as the
percentage re-endothelialization (absence of Evans blue staining) of a
5-mm arterial segment, 5 mm distal to the aortic bifurcation.
Flow cytometry
As published (4), saphenous venous blood samples were
analyzed with flow cytometry (Becton Dickinson LSR II; BD
Biosciences, Franklin Lakes, NJ). After blocking with Fc
receptor blocking reagent (BD Biosciences) at a 1:10 dilution
(10), Sca-1+/Flk-1+ and c-Kit+ cells were labeled with fluorophore-
conjugated primary antibodies (BDBiosciences) at a 1:250 dilution
(11–13) and quantified as a percentage of events within
the lymphocyte gate, defined by forward-scatter and side-scatter
properties. Control specimens, labeled with corresponding
fluorophore-conjugated isotype control antibodies (BD Bio-
sciences) at a 1:250 dilution (14–16), were used to define
the threshold for antigen expression and to subtract
nonspecific fluorescence.
Cell culture derivation of myeloid angiogenic cells
Mononuclear cells were isolated from blood and spleen,
then cultured in EGM-2 medium supplemented with a EGM-2
Bullet Kit (Lonza, Basel, Switzerland) and 20% fetal calf serum;
these are identical to the methods used in our previous work to
derive cells referred to as angiogenic progenitor cells in our
previous publications (4). As per a recent consensus agreement
on “endothelial progenitor” nomenclature, we now refer to
these as myeloid angiogenic cells, which promote vascular
regeneration in a paracrine manner. These cells were enu-
merated on day 7, based on DiI-acetylated low-density lipo-
protein uptake and Ulex europaeus lectin–fluorescein
isothiocyanate binding (17). The paracrine function of spleen-
derived cells was assessed by deriving conditioned medium, as
previously described (4). The impact of conditioned medium on
human umbilical vein endothelial cell (HUVEC; Promocell,
Heidelberg, Germany) scratch wound closure was defined.
Pulmonary endothelial cell culture
Endothelial cells were isolated from the lungs of 4- to
6-week-old mice; although they were younger than mice used in
our other experiments, we found that juvenile lungs produced
higher-quality cell preparations for functional studies. As
previously described, CD146+ pulmonary endothelial cells
(PECs) were isolated with immunomagnetic microbeads (Miltenyi
Biotec, Bergisch Gladbach, Germany) and cultured in MV2 me-
dium (Promocell), supplemented with 10% fetal calf serum, 100
units/mL penicillin, and 100 mg/mL streptomycin (9). Cells were
studied at passage 2 to 3.
Quantification of endothelial superoxide production
PECs were loaded with 10 mmol/L dihydroethidium and
analyzed with a plate reader apparatus (FlexStation; Molecular
Devices, San Jose, CA) as previously described (2).
Endothelial scratch wound assay
Awound was formed in confluent PECs or human umbilical
vein endothelial cells with a WoundmakerTM tool (Essen Bio-
sciences, Ann Arbor, MI). Phase contrast images were collected
(Olympus CX-41; Olympus Corporation, Tokyo, Japan) im-
mediately and 12 hours later, and the percentage area reduction
(wound closure) calculated with ImageJ (National Institutes of
Health, Bethesda, MD).
Endothelial migration assay
As described, PECs were seeded in a Boyden chamber ap-
paratus to define migration toward 50 ng/mL vascular endo-
thelial growth factor (VEGF)-A165 (R&D Systems, Minneapolis,
MN) (18). The number of migrating cells per microscopic field
was counted under standard light microscopy and presented as
net migration by subtracting the number of cells migrating in
paired control experiments without VEGF-A165 gradient.
Endothelial cell proliferation assay
Subconfluent PECs were exposed to 10 mM 5-ethynyl-20-
deoxyuridine (EdU) in standard growth medium for 4 hours
before labeling with Alexa Fluor-488 with a flow cytometry EdU
Click-iT Kit (Invitrogen, Carlsbad, CA). The percentage of EdU+
cells was defined with flow cytometry (Becton Dickinson LSR II).
Immunoblotting
As published (7), protein extracts were resolved on 4% to
12%Bis-Tris gels (Invitrogen) and transferred to polyvinylidene
fluoride membranes. Blots were probed with the following
primary antibodies, withmanufacturers and dilutions presented
in parentheses: insulin receptor-b (Santa Cruz Biotechnology,
Dallas, TX; 1:500) (19), b-actin (Cell Signaling Technology,
Danvers, MA; 1:20,000) (20), eNOS (BD Biosciences, 1:1000)
(21), phospho-eNOS S1177 (BD Biosciences, 1:1000) (22), Akt
(Cell Signaling Technology, 1:1000) (23), and phospho-Akt
S473 (Cell Signaling Technology, 1:2000) (24). Peroxidase-
conjugated secondary antibodies (GE Healthcare, Chicago,
IL) were then applied at a 1:1000 dilution (25, 26), before
increased chemiluminescence (Millipore, Burlington, MA).
Quantitative RT-PCR Reaction
PECs were lysed in TRI-Reagent (Sigma) and RNA isolated
as previously described (7). After reverse transcription (High
Capacity cDNAReverse Transcription Kit; Applied Biosystems,
Waltham, MA), quantitative polymerase chain reaction for the
human and murine insulin receptor was conducted exactly
as published (including primary sequences) (7), and cycle
threshold was normalized to b-actin using the equation
22DCT 3 100. Primer details are presented in Table 1.
Statistics
Data are presented as mean with SEM in parentheses. Two-
sided unpaired Student t tests were used for comparisons be-
tween IRKO and IRKO-hIRECO mice to test the hypothesis
that endothelial normalization of insulin receptor expression
would rescue the vascular phenotype of IRKO. WT littermate
data are presented solely for reference in key experiments; our
published data already show impaired vascular function and
repair in IRKO vs WT littermates (3, 4). Statistical significance
was defined as P , 0.05.
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Results
IRKO-hIRECO mice have endothelial-specific
restoration of insulin receptor expression
and signaling
Human insulin receptor mRNA was present in IRKO-
hIRECO PECs but not in nonendothelial cells from lung
preparations (Fig. 1A). Moreover, murine insulin re-
ceptor mRNA was comparable in IRKO and IRKO-
hIRECO mice, both being significantly lower than
in WT littermates (Fig. 1B). Despite testing multiple
“species-specific” insulin receptor antibodies, we were
unable to find any that unequivocally discriminated
between human and mouse isoforms. However, immu-
noblotting with an antibody reactive to human and
murine insulin receptor demonstrated IRKO-hIRECO
expression to be intermediate to IRKO and WT
(Fig. 1C). Notably, “basal” phosphorylation of Akt and
eNOS was reduced in freshly isolated (i.e., noncultured)
endothelial cells from nonfasted IRKO-hIRECO vs
IRKO mice and was comparable to that of WT controls
(Supplemental Fig. 1A and 1B). Because this finding may
reflect differences in the in vivo exposure of these cells to
insulin and other ligands regulating Akt signaling, we
also assessed culture-expanded lung endothelial cells
(Supplemental Fig. 1C and 1D). Interestingly, these
findings suggested that after 4 hours of quiescence in
serum-free media and 15 minutes after exposure to
150 nM insulin, Akt phosphorylation was similar in IRKO,
IRKO-hIRECO, and WT mice.
Systemic glucose homeostasis is comparable in IRKO
and IRKO-hIRECO mice
Weight gain of IRKO-hIRECO mice was comparable
to that of IRKO mice throughout the study period
(Fig. 2A). Notably, there was also no difference in glucose
or insulin tolerance (Fig. 2B and 2C) or fasting serum
insulin concentration (Fig. 2D) between IRKO and
IRKO-hIRECO mice. Therefore, any differences in vas-
cular function between IRKO and IRKO-hIRECO mice
are unlikely to be related to altered glucose homeostasis.
Moreover, no statistically significant differences were
noted between WT and IRKO or IRKO-hIRECO mice
(Fig. 2A–2D), implying that endothelial insulin receptors
are not essential for systemic glucose homeostasis and so
may serve alternative roles.
IRKO-hIRECO mice exhibit rescue of vascular
endothelial dysfunction
IRKO mice are known to exhibit endothelial dys-
function (3), so next we characterized aortic vasomotion.
IRKO-hIRECO mice showed significantly greater
endothelium-dependent relaxation in response to ace-
tylcholine than IRKOmice (Fig. 3A and 3B) but identical
endothelium-independent responses to SNP (Fig. 3C).
Moreover, an ex vivoNO synthase activity assay showed
increased insulin-stimulated NO production in IRKO-
hIRECO vs IRKO mice (Fig. 3D); importantly, there was
no difference betweenWT and IRKO-hIRECOmice, and
IRKO mice were impaired compared with WT mice (P,
0.05). We have previously demonstrated oxidative stress
due to increased superoxide abundance in 6-month-old
IRKO mice (6); however, superoxide abundance was
similar in 4- to 6-week-old IRKO and IRKO-hIRECO
PECs (Fig. 3E). IRKO mice displayed increased vaso-
constriction in response to phenylephrine, which was
completely normalized (not statistically different from
WT levels) in IRKO-hIRECO mice (Fig. 3F and 3G).
Furthermore, the normalized contractile response to
phenylephrine in IRKO-hIRECO was completely lost in
the presence of the NO synthase inhibitor L-NMMA
(Fig. 3H), suggesting increased basal vascular NO
Figure 1. Endothelial insulin receptor expression is normalized in IRKO-hIRECO. (A) Human insulin receptor (hIR) mRNA is detected only in PECs
isolated from lungs of IRKO-hIRECO mice and was undetectable in nonendothelial cells (NECs) (n . 4 per group). (B) Murine insulin receptor
(mIR) mRNA is comparable in IRKO and IRKO-hIRECO pulmonary endothelial cells, and both are less abundant than in WT littermates (n . 4
per group). (C) Total insulin receptor (IR) protein expression is greater in IRKO-hIRECO than IRKO pulmonary endothelial cells (n = 5, 9, and 13,
respectively); representative immunoblots are presented above the panel. Sample sizes are presented in the order WT, IRKO, and IRKO-hIRECO.
*P , 0.05. n.s., nonsignificant for IRKO vs IRKO-hIRECO.
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production. Systolic blood pressure measurement pro-
vided in vivo corroboration of these data, with that of
IRKO-hIRECO mice being lower than that of IRKO and
statistically comparable to WT mice [IRKO-hIRECO
mean 97.3 (SEM 2.5) mm Hg, IRKO 105.9 (3.0) mm
Hg, WT 94.8 (3.0) mm Hg; Fig. 3I].
IRKO-hIRECO mice exhibit rescue of
re-endothelialization after arterial injury
Re-endothelialization of the injured femoral artery is
also known to be impaired in IRKO mice (4). IRKO-
hIRECO mice showed augmented re-endothelialization
compared with IRKO mice, which were statistically
comparable to WT mice (Fig. 4A). Notably, this finding
was not associated with differential in vitro formation of
myeloid angiogenic cells between IRKO and IRKO-
hIRECO blood (Fig. 4B) or in the capacity of condi-
tioned medium from these cells to promote endothelial
scratch wound closure (Fig. 4C). Moreover, we noted no
differences between IRKO and IRKO-hIRECO mice in
the abundance of circulating Sca1+/Flk1+ (Fig. 4D) or
c-Kit+ (Fig. 4E) progenitor cells, which have previously
been shown to be less abundant in IRKO than in WT
mice (4). These data suggest that increased vascular re-
pair in IRKO-hIRECO mice may not be related to
changes in circulating proreparative
cells. Importantly, migration of IRKO-
hIRECO PECs toward VEGF was
increased in a Boyden chamber appa-
ratus (Fig. 4F), being statistically
comparable to that of WT mice.
Moreover, PEC scratch wound closure
was significantly greater in IRKO-
hIRECO mice (Fig. 4G), although it
remained less than in WT mice (P ,
0.05), and this difference was not as-
sociated with any change in PEC
proliferation defined by EdU in-
corporation (Fig. 4H), suggesting that
the increased migration noted ear-
lier may underlie improved scratch
wound closure.
Discussion
We have evaluated restored endothe-
lial insulin receptor expression in the
context of systemic insulin receptor
haploinsufficiency and demonstrated
that it does not affect whole-body
glucose metabolism, normalizes blood
pressure and macrovascular NO bio-
availability, and promotes endothelial
repair after denuding arterial injury, potentially via in-
creased endothelial cell migration. By rescuing vascular
dysfunction with endothelium-specific restoration of in-
sulin receptor expression, we demonstrated that off-
target “compensatory” changes in endothelial gene
expression do not account for the vascular dysfunction
of IRKOmice. In other words, we have strengthened the
evidence base showing that endothelial insulin receptor
expression is essential for normal vascular function
and repair.
The comparable glucose homeostasis of IRKO and
IRKO-hIRECO mice concurs with reports that vascular
endothelial insulin receptor knockout mice exhibit pre-
served insulin sensitivity (27). Moreover, recent elegant
imaging studies have shown that skeletal muscle trans-
endothelial insulin transport depends on fluid phase
transport and not insulin receptors (28). Although
studies of vascular endothelial insulin receptor knockout
mice produced with a different Cre line have shown
slowed insulin signaling kinetics in a tissue-specific
manner, these used suprapharmacological insulin doses
(.250 times greater than in our insulin tolerance tests)
and so are of unclear relevance to physiology (29).
Notably, endothelial loss of insulin receptor substrate-2
is also associated with impaired systemic glucose
Figure 2. Weight gain and systemic glucose metabolism are unchanged in IRKO-hIRECO
mice. (A) Weight gain from weaning to 4 months of age is indistinguishable between
IRKO-hIRECO, IRKO, and WT littermates (n . 10 per group). (B) Glucose tolerance was
comparable in IRKO-hIRECO and IRKO mice (n = 9, 8, and 7, respectively). (C) Insulin
tolerance was comparable in IRKO-hIRECO and IRKO mice (n = 8, 10, and 10, respectively).
(D) Serum fasting insulin concentration was comparable in IRKO-hIRECO and IRKO mice
(n = 9, 8, and 8, respectively). Sample sizes are presented in the order WT, IRKO, and
IRKO-hIRECO. n.s., nonsignificant for IRKO vs IRKO-hIRECO.
doi: 10.1210/en.2018-00215 https://academic.oup.com/endo 2921
Downloaded from https://academic.oup.com/endo/article-abstract/159/8/2917/4995800
by University of Leeds user
on 06 August 2018
metabolism, which can be rescued by NO donors,
reflecting the importance of tissue perfusion to insulin
action (30). However, this association does not neces-
sarily imply that endothelial insulin receptors are needed
for systemic glucose homeostasis. Although debate is
likely to continue, our work and the wider literature
suggest that endothelial insulin receptors are not critical
effectors of systemic glucose metabolism. This important
observation raises the question of why endothelial cells
express insulin receptors.
The association between reduced insulin signaling and
endothelial dysfunction is well established and is char-
acterized by diminished endothelial NO generation and
oxidative stress resulting from increased superoxide
production (31–33). Although we noted no difference
in endothelial superoxide between IRKO and IRKO-
hIRECO mice, this finding may reflect the young age
of mice used for endothelial cell isolation in our studies
(4 to 6 weeks); notably, we have previously shown
greater vascular superoxide abundance in 6-month-old
Figure 3. IRKO-hIRECO mice have normalized vasodilator response, NO bioavailability, and blood pressure. (A) Acetylcholine-induced
vasodilatation is greater in IRKO-hIRECO than in IRKO and comparable to that in WT mice (n = 7, 10, and 8, respectively). (B) Acetylcholine EC50
data derived from panel (A). (C) SNP-induced endothelium-independent vasodilatation is comparable in IRKO-hIRECO, IRKO, and WT mice (n = 4,
7, and 6, respectively). (D) Insulin-stimulated NO synthase activity is greater in IRKO-hIRECO than in IRKO mice (n = 6, 5, and 6, respectively). (E)
Superoxide abundance was similar in IRKO-hIRECO and IRKO mice but greater than in WT mice (n = 6, 7, and 6, respectively). (F) PE-induced
vasoconstriction is lower in IRKO-hIRECO than in IRKO mice and comparable in WT mice (n = 7, 10, and 8, respectively). (G) PE EC50 data
derived from panel (F). (H) Diminished PE-induced vasoconstriction in IRKO-hIRECO mice is caused by increased NO bioavailability as it is
significantly abrogated by the NO synthase antagonist L-NMMA (n = 5 and 5, respectively). (I) Systolic blood pressure is lower in IRKO-hIRECO
than in IRKO mice and comparable in WT mice (n = 10, 19, and 18, respectively). Sample sizes are presented in the order WT, IRKO, and
IRKO-hIRECO. *P , 0.05. EC50, half-maximal effective concentration; n.s., nonsignificant for IRKO vs IRKO-hIRECO.
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but not 2-month-old IRKO mice (6). Mechanistically,
excessive superoxide is an important mediator of the
vascular disease associated with insulin resistance, for
example by diminishing NO bioavailability and oxidiz-
ing lipids, proteins, and DNA (2). Multiple assays in
adult IRKO-hIRECO mice showed rescued insulin-
induced and isometric tension–induced NO generation,
potentially explaining their greater vasomotion and
lower blood pressure. Mechanistically, NO has also been
proposed to contribute to normal vascular homeostasis
by suppressing leukocyte adhesion molecule expression,
impeding platelet activation, and retarding vascular
smooth muscle proliferation, among many other effects
(34). Interestingly, we observed lower phosphorylation
of Akt and eNOS in freshly isolated endothelial cells from
IRKO-hIRECO (and WT) mice vs IRKO mice, poten-
tially suggesting compensatory in vivo adaptations to
maintainNO production in IRKOmice. Furthermore, we
saw no differences in serum-free and insulin-stimulated
Akt phosphorylation of culture-expanded endothelial cells
from IRKO, IRKO-hIRECO, and WT mice. This finding
may suggest that differences in signaling related to altered
receptor expression occur in a narrow range of ligand
concentrations, but it is also possible that the receptor has
ligand-independent roles, as is well established for other
receptor tyrosine kinases (35).
Figure 4. Endothelial repair is normalized in IRKO-hIRECO mice and is associated with increased endothelial cell migration. (A) Re-endothelialization
of wire-injured femoral artery is greater in IRKO-hIRECO than in IRKO mice and comparable in WT mice (n = 6, 14, and 12, respectively);
representative images are presented adjacent. (B) In vitro myeloid angiogenic cell formation was comparable between blood from IRKO and IRKO-
hIRECO mice, both of which were lower than in WT mice (n = 5, 5, and 6, respectively). (C) Conditioned medium from IRKO-hIRECO and IRKO
spleen-derived myeloid angiogenic cells was equally effective in promoting endothelial scratch wound closure (n = 4, 4, and 4, respectively). No
differences were noted in the abundance of (D) circulating Sca-1+/Flk-1+ or (E) c-Kit+ progenitor cells between IRKO-hIRECO and IRKO mice,
although the former were lower in IRKO-hIRECO and IRKO than WT mice (n = 7, 8, and 9, respectively). (F) PEC migration toward VEGF-A165
in a Boyden chamber apparatus is greater in IRKO-hIRECO than in IRKO mice and comparable in WT mice (n = 9, 9, and 9, respectively). (G)
Closure of a scratch wound formed in PEC was also greater in IRKO-hIRECO than IRKO mice, although both were lower than in WT mice (n =
6, 9, and 6, respectively). (H) No difference in PEC proliferation was noted between IRKO-hIRECO and IRKO mice (n = 5, 6, 5, respectively).
Sample sizes are presented in the order WT, IRKO, and IRKO-hIRECO. *P , 0.05. AUC, area under the curve; n.s., nonsignificant for IRKO
vs IRKO-hIRECO.
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Our data also provide evidence that insulin receptor
expression in the endothelium per se is essential for
normal vascular repair, advancing our observations in
mice with whole body insulin receptor haploinsufficiency
(4). Although our previous work suggested that altered
circulating proreparative cells may diminish vascular
repair in IRKO vs WT mice, we found no rescue of these
parameters in IRKO-hIRECO mice; however, we did
observe a clear improvement in endothelial cell migra-
tion. Insulin is an established inducer of endothelial cell
migration in vitro (36–39), with signaling via PI3-kinase
to the cytoskeletal regulator Rac1 often being implicated.
Furthermore, insulin has been shown to promote local
ATP production during the cell membrane remodeling
necessary for migration, by mobilizing glycolytic en-
zymes from the actin cytoskeleton (36). Therefore, the
differences between IRKO and IRKO-hIRECO endo-
thelial cell migration are plausible, and this phenomenon
is key to the re-endothelialization of denuded arteries in
vivo (40). Our findings advance the literature linking
insulin’s cognate receptor to in vivo vascular repair by
suggesting an endothelial cell autonomous contribution,
rather than effects solely in other cell lineages partici-
pating in tissue repair.
Finally, it is important to contrast the adverse vascular
phenotype we have recently reported in hIRECOmice (7)
with the normalized vascular function of IRKO-hIRECO
mice presented in this article. Both models have un-
perturbed glucose tolerance and insulin sensitivity, fur-
ther emphasizing the disconnect between the metabolic
and vascular consequences of endothelial insulin re-
ceptor manipulation. These data, together with the wider
literature discussed earlier, indicate that modest per-
turbations of endothelial insulin receptor expres-
sion or signaling have important consequences for
vascular physiology.
It is also important to acknowledge some limitations
of our work. First, this study intended to dissect the role
of endothelial insulin receptors in normal physiology
rather than model the complex multilevel signaling ab-
normalities of insulin resistance associated with obesity
and type 2 diabetes. We therefore do not extrapolate our
findings to human disease, or even other murine models
of diabetes, and it will be important for future research to
extend our work in these models. Second, it is likely that
the improvements in vascular function and repair are
mediated by complex mechanisms, as supported by the
unexpectedly increased Akt and eNOS phosphorylation
in freshly isolated IRKO endothelial cells. Moreover, it is
likely that expression of the insulin receptor varies
among endothelial cells, reflecting their established
structural and functional heterogeneity within and be-
tween vascular beds. Indeed, recent work suggests greater
expression of the insulin receptor in the cerebral vs
pulmonary vascular beds, although with broadly stable
expression in microvascular and macrovascular endo-
thelial cells within these beds (41, 42). Finally, it is
beyond the scope of this study to define detailed mech-
anistic pathways for restored endothelial function and
for vascular repair; future studies will be needed to ad-
dress both. In particular, these studies will need to further
define the molecular perturbations (e.g., to signaling
events and local redox milieus) caused by altered
endothelial cell insulin receptor expression and
to mechanistically link these perturbations to altered
cellular and vascular behavior by studying multiple
vascular beds.
In conclusion, we provide evidence that restoration of
endothelial insulin receptor expression alone is sufficient
to prevent the vascular dysfunction caused by systemi-
cally reduced insulin signaling. This study emphasizes the
pivotal importance of the endothelium as a target of
insulin during normal vascular physiology.
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